Royal Marsden NHS Foundation Trust: all 272 studies

Page 2 of 3. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.

• A Phase Ib Combination Study of Rituximab, TinostamustinEAnd CHeckpoint Inhibition With Pembrolizumab in Relapsed/Refractory DLBCLWithdrawnNCT04279938Phase 1
• Men's Experience of Prostate BiopsyCompletedNCT04274725
• Lung Nodule Imaging Biobank for Radiomics and AI ResearchStatus unknownNCT04270799
• Optimising Radiation Therapy in Head and Neck Cancers Using Functional Image-Guided Radiotherapy and Novel BiomarkersStatus unknownNCT04242459Phase 1/2
• WaKING: Wnt and checKpoint INhibition in Gastric CancerActive, not recruitingNCT04166721Phase 1/2
• Evaluation of Tongue Base MucOsectomy & Step sErial SectioningActive, not recruitingNCT04151134
• Identification of Molecular Biomarkers for Thyroid CancerStatus unknownNCT04133870
• Whole Body Magnetic Resonance Imaging StudyStatus unknownNCT04117594
• Exploratory Study of Molecular Characterization in Patients With Metastatic Germ Cell Tumours Refractory/Resistant to Platinum TreatmentStatus unknownNCT03980587
• Evaluation of an Educational Intervention for Women With Breast PainStatus unknownNCT03936842Not applicable
• The Effect of ENZAlutamide on the Anti-Xa Levels of Patients Receiving DOACsStatus unknownNCT03920566
• Gamma Delta T Cells in AMLStatus unknownNCT03885076
• iSCORE: Immunotherapy Sequencing in COlon and REctal CancerActive, not recruitingNCT03867799Phase 2
• Evaluating a Digital Tool for Supporting Breast Cancer PatientsStatus unknownNCT03866655Not applicable
• Lifestyle Changes Using Digital Technology in Colorectal CancerStatus unknownNCT03849352Not applicable
• A Prospective Translational Tissue Collection Study in Early and Advanced Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumours to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic BiomarkersStatus unknownNCT03840460
• A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric CancerStatus unknownNCT03829345Phase 2
• Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon CancerTerminatedNCT03827044Phase 3
• Epigenetic Modulation of the immunE Response in GastrointEstinal Cancers (EMERGE)Status unknownNCT03812796Phase 2
• Gustatory Function Following Radiotherapy to the Head and NeckStatus unknownNCT03738657
• Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast CancerCompletedNCT03684733
• Prostate Radiotherapy Integrated With Simultaneous MRI (The PRISM Study)Status unknownNCT03658525Not applicable
• HRQoL in Advanced Soft Tissue Sarcoma Patients Treated With Chemotherapy.Status unknownNCT03621332
• Simplification of Low Level Internal DosimetryCompletedNCT03580161
• Machine Learning in Myeloma ResponseStatus unknownNCT03574454Not applicable
• TITAN (Tumoural Injection of T-VEC and Isolated Limb Perfusion)CompletedNCT03555032Phase 1/2
• Radiation Exposure Awareness From Patients Undergoing Nuclear Medicine Diagnostic ScansStatus unknownNCT03458585
• MR-guided RAdiotherapy to Breast With Dose Escalation to regionaL Lymph NodEsCompletedNCT03405519Not applicable
• Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric CancerActive, not recruitingNCT03399071Phase 2
• Lab-on-a-chip Detection of Cervical Cancer Tumour MarkersStatus unknownNCT03380741
• Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC AdenocarcinomaWithdrawnNCT03361319Phase 1/2
• Enhancing Diagnosis in Chronic B-cell Lymphoproliferative Disorders Using Next-Generation SequencingActive, not recruitingNCT03344809
• London Investigation Into diElectric Scanning of LesionsStatus unknownNCT03302819Not applicable
• Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0Status unknownNCT03265158
• Simulating Outcomes From Breast Conserving Surgery Using 3D Surface ImagingStatus unknownNCT03250260Not applicable
• Laboratory Studies Into the Pathology of LeukaemiaStatus unknownNCT03233763
• TRACERx Renal CAPTURE Sub-studyStatus unknownNCT03226886
• Pilot Study for 3-Dimensional Surface Imaging in Implant-based Breast ReconstructionStatus unknownNCT03203252
• Surgical Anatomy and 'Waisting' of the sIgmoid SpEcimenCompletedNCT03135808
• Impact of Radiotherapy on Patients Undergoing DIEP Flap Breast ReconstructionStatus unknownNCT03072316
• Improving Diagnosis in Idiopathic Cytopenia Using Gene SequencingStatus unknownNCT03026751
• Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib MonotherapyCompletedNCT03010722
• Combination Study of Guadecitabine/ASTX727 and PembrolizumabActive, not recruitingNCT02998567Phase 1
• PROSPECT-C: A Study of Biomarkers of Response or Resistance to Anti-EGFR Therapies in Metastatic Colorectal CancerCompletedNCT02994888
• A Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer RadiotherapyStatus unknownNCT02978014Phase 2
• Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric CarcinomaStatus unknownNCT02884453Phase 2
• The HeartSpare Study (Stage I)CompletedNCT02794324Phase 2/3
• Primary Radiotherapy And DIEP flAp Reconstruction TrialCompletedNCT02771938Not applicable
• The HeartSpare Plus 1B TrialCompletedNCT02771353Phase 2
• Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial OligometastasesStatus unknownNCT02759783Phase 2/3
• Tenovus Cancer Choirs Study: the Benefits of Singing for Those Affected by CancerStatus unknownNCT02756780Not applicable
• Developing a Symptom List for Children With CancerStatus unknownNCT02726815
• Art Therapy for Pain Relief in Breast Cancer PatientsStatus unknownNCT02680236
• Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy TrialActive, not recruitingNCT02678182Phase 2
• A Study of Anti-PD-1 (Pembrolizumab) Therapy in Metastatic Melanoma (ADAPTeM)WithdrawnNCT02663258Phase 2
• Using an Electronic Nose to Predict Gastrointestinal Consequences of Pelvic RadiotherapyStatus unknownNCT02649491
• GI Consequences Economic EvaluationCompletedNCT02647450
• The Effect of an Aromatherapy Intervention on Sleep in the ICUStatus unknownNCT02623686Not applicable
• Comparing Immobilisation Shells in Cranial RadiotherapyCompletedNCT02599142Not applicable
• Evaluation Of CanADVICE+®M-Health System To Support Breast Cancer Patients Receiving CapecitabineCompletedNCT02580396Not applicable
• Pembrolizumab in Muscle Invasive/Metastatic Bladder CancerActive, not recruitingNCT02560636Phase 1
• Mri IN STaging REctal Polyp PlanesStatus unknownNCT02532803Not applicable
• Gynaecologic Organ Segmentation and Motion Tracking Using UltrasoundStatus unknownNCT02503917
• Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and ImagingCompletedNCT02486094
• A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR)TerminatedNCT02446860Phase 2
• Phase I Trial of VS-6766 Alone and in Combination With EverolimusCompletedNCT02407509Phase 1
• PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclibCompletedNCT02389842Phase 1
• Phase I Trial of ONX-0801 Once Weekly or Alternate WeeklyCompletedNCT02360345Phase 1
• Trial of Olaparib in Combination with AZD5363 (ComPAKT)CompletedNCT02338622Phase 1
• The Use of 3D Surface Imaging in the Objective Assessment of Breast Conserving TherapyStatus unknownNCT02304614
• Tissue Collection for Biomarkers Determining Resistance to IbrutinibStatus unknownNCT02267590
• PPALM-Palm Oil and Pentoxifylline Against Late MorbidityCompletedNCT02230800Phase 2
• Phase I Study to Assess Safety of AZD6738 Alone and in Combination With Radiotherapy in Patients With Solid TumoursStatus unknownNCT02223923Phase 1
• A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel.CompletedNCT02193633Phase 1
• Development of a Personalised Care Plan Designed to Reduce Chronic Post-Operative Pain Following Breast SurgeryStatus unknownNCT02170415Not applicable
• Parotid-sparing IMRT for Nasopharyngeal CancerCompletedNCT02149641
• A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and NeckCompletedNCT02149602
• The SPARC Trial: Stereotactic Prostate Ablative Radiotherapy Using CyberknifeStatus unknownNCT02145494Phase 2
• Rapid Medical Donation Programme for Breast CancerStatus unknownNCT02126800
• The FOCCUS Study: "Focusing on Cancers Chemotherapys' Untreated Symptoms"CompletedNCT02121626
• Feasibility of a Molecular Characterisation Approach to TreatmentStatus unknownNCT02112357
• A Study of Intensity-modulated Radiotherapy in Patients With Squamous Cell Carcinoma of Unknown Primary (SCCUP) of the Head and NeckCompletedNCT02112344Not applicable
• A Prospective Longitudinal Cohort Study Looking at the Difference in Carotid Intima-medial Thickness Between Irradiated and Unirradiated Carotid Arteries in Patients With Head and Neck CancerStatus unknownNCT02069964
• Phase II Study of Whole or Partial Parotid Sparing Intensity Modulated Radiotherapy in Patients With Head and Neck CancersStatus unknownNCT02068313
• Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)Status unknownNCT02060656Phase 2
• A Cross-sectional Study Looking at the Effect of Radiotherapy on Carotid Intima-medial Thickness in Head and Neck CancerCompletedNCT02060643
• A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and HypopharynxCompletedNCT02055989Phase 1/2
• International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly PaclitaxelStatus unknownNCT02051868Phase 2
• Low Rectal Cancer Study (MERCURY II)Status unknownNCT02005965
• Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) TrialStatus unknownNCT01995942
• Incidence of Postoperative Ketosis and Metabolic AcidosisStatus unknownNCT01860001
• Validation of a Nutrition Screening ToolCompletedNCT01851928
• Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified TumoursStatus unknownNCT01795768Phase 2
• CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II StudyStatus unknownNCT01719835Phase 2
• Pain: Screen and TreatStatus unknownNCT01716780Phase 3
• Prostate Advances in Comparative EvidenceActive, not recruitingNCT01584258Phase 3
• A Survivorship Care Plan for Gynaecological Cancer PatientsCompletedNCT01582906
• Evaluation of the Hospital2Home Palliative Care Service for Patients With Advanced Progressive Lung DiseaseStatus unknownNCT01450644Phase 2
• Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)CompletedNCT01278004Phase 2
• Reflexology or Aromatherapy Massage in Relieving Symptoms in Patients With CancerCompletedNCT01217424Not applicable

← Royal Marsden NHS Foundation Trust overview and focus areas